These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30280246)

  • 1. Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings.
    Giganti F; Tang L; Baba H
    Eur Radiol; 2019 Apr; 29(4):1743-1753. PubMed ID: 30280246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and
    Tang L; Wang XJ; Baba H; Giganti F
    Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
    J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient in Gastric Cancer Staging.
    Soydan L; Demir AA; Torun M; Cikrikcioglu MA
    Curr Med Imaging; 2020; 16(10):1278-1289. PubMed ID: 32108000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: Comparison with two-dimensional multidetector row CT.
    Jang KM; Kim SH; Lee SJ; Lee MW; Choi D; Kim KM
    Clin Radiol; 2014 Aug; 69(8):827-35. PubMed ID: 24837701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative T and N staging of gastric cancer: magnetic resonance imaging (MRI) versus multi detector computed tomography (MDCT).
    Maccioni F; Marcelli G; Al Ansari N; Zippi M; De Marco V; Kagarmanova A; Vestri A; Marcheggiano-Clarke L; Marini M
    Clin Ter; 2010; 161(2):e57-62. PubMed ID: 20499021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
    Salem S; Houseni M; Zidan L; Kandil A
    Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging in the depiction of gastric cancer: initial experience.
    Tang L; Sun YS; Li ZY; Cao K; Zhang XY; Li XT; Ji JF
    Abdom Radiol (NY); 2016 Jan; 41(1):2-9. PubMed ID: 26830605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
    Tsuchida T; Morikawa M; Demura Y; Umeda Y; Okazawa H; Kimura H
    J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response.
    Fliedner FP; Engel TB; El-Ali HH; Hansen AE; Kjaer A
    BMC Cancer; 2020 Feb; 20(1):134. PubMed ID: 32075610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DW MRI at 3.0 T versus FDG PET/CT for detection of malignant pulmonary tumors.
    Zhang J; Cui LB; Tang X; Ren XL; Shi JR; Yang HN; Zhang Y; Li ZK; Wu CG; Jian W; Zhao F; Ti XY; Yin H
    Int J Cancer; 2014 Feb; 134(3):606-11. PubMed ID: 23893610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis.
    Wu LM; Hu J; Gu HY; Hua J; Xu JR
    Eur J Cancer; 2013 Feb; 49(3):572-84. PubMed ID: 23000072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer.
    Joo I; Lee JM; Kim JH; Shin CI; Han JK; Choi BI
    J Magn Reson Imaging; 2015 Mar; 41(3):814-21. PubMed ID: 24677322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
    Lee DH; Kim SH; Joo I; Hur BY; Han JK
    Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
    Giannarini G; Petralia G; Thoeny HC
    Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
    Liu LP; Zhang XX; Cui LB; Li J; Yang JL; Yang HN; Zhang Y; Zhou Y; Tang X; Qi S; Fang Y; Zhang J; Yin H
    Clin Respir J; 2017 Mar; 11(2):151-158. PubMed ID: 25918835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker.
    Giganti F; Antunes S; Salerno A; Ambrosi A; Marra P; Nicoletti R; Orsenigo E; Chiari D; Albarello L; Staudacher C; Esposito A; Del Maschio A; De Cobelli F
    Eur Radiol; 2017 May; 27(5):1831-1839. PubMed ID: 27553932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of Lauren classification for gastric adenocarcinoma using diffusion MRI with a fractional order calculus model.
    Karaman MM; Tang L; Li Z; Sun Y; Li JZ; Zhou XJ
    Eur Radiol; 2021 Aug; 31(8):5659-5668. PubMed ID: 33616764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.